Business Context and Reporting Period
This Form 8-K is filed by Sunshine Heart, Inc. (not Nuwellis, Inc.) on March 23, 2017. The report details unregistered sales of equity securities and other events related to warrant exercises and the conversion of preferred stock.
Key Financial Metrics and Capital Structure
- Cash Proceeds: The Company received gross cash proceeds of $676,353 from the exercise of warrants.
- Shares Issued (Warrants): 333,179 shares of common stock were issued upon warrant exercise.
- Shares Issued (Conversion): 613,251 shares of common stock were issued from the conversion of Series C and Series D Convertible Preferred Stock.
- Total Outstanding Shares: As of March 23, 2017, 2,690,674 shares of common stock are outstanding.
- Preferred Stock Status: All Series C and Series D Convertible Preferred Stock have been converted in full; none remain outstanding.
Material Changes
Between March 22, 2017, and March 23, 2017, the Company completed the full conversion of its Series C and Series D Convertible Preferred Stock. Additionally, institutional investors exercised warrants to purchase 333,179 shares, triggering the issuance of an equal number of Replacement Warrants with an exercise price of $2.16 per share. The filing notes that prior equity issuances had previously reset the conversion/exercise price of remaining securities to $2.03.
Outlook, Risks, and Unusual Items
The transactions were conducted under exemptions provided by Rule 506 of Regulation D and Section 4(a)(2) of the Securities Act. The filing highlights a mechanism where the issuance of additional Replacement Warrants at a lower price could further decrease the exercise price of warrants held by investors. No forward-looking guidance or revenue projections are provided in this specific filing.
Investor Verification Checklist
- Verify the total number of outstanding shares (2,690,674) and the elimination of Series C and D preferred stock.
- Confirm the terms of the Replacement Warrants issued at $2.16 per share and potential for further price resets.
- Review the "Prior Report" (Form 8-K filed March 22, 2017) for the full context of the letter agreement with Sabby Healthcare Master Fund Ltd. and Sabby Volatility Warrant Master Fund Ltd.
- Note that the filing entity is Sunshine Heart, Inc., not Nuwellis, Inc.